Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
Volunteers
Health Professionals
What is the purpose of this trial?
This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat may provide information about the patient's leukemia that is important when deciding how to best treat it, and may help doctors find better ways to diagnose and treat leukemia in children, adolescents, and young adults.
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Aron Flagg, MD
- Asher Marks, MD
- Claudia Auerbach, APRN
- Farzana Pashankar, MD, MRCP, MBBS
- Juan Vasquez, MD
- Kate Hallissey
- Lakshmanan Krishnamurti, MD
- Mary Jane Hogan, MD, MPH, FAAP
- Michaela Russell
- Nitya Bakshi, MBBS, MS
- Prasanna Ananth, MD, MPH
- Rozalyn Levine Rodwin, MD
- Stephanie Prozora, MD
- Vidya Puthenpura, MD, MHS, FAAP
- Last Updated08/30/2024
- Study HIC#2000034939